JAZZ Venture Partners is a venture capital firm focused on technologies that extend the boundaries of human performance.
Business Model:
Revenue: $0
Employees: 0-0
Address: 548 Market Street,
City: San Francisco
State: CA
Zip: 94104
Country: US
JAZZ Venture Partners is the leading venture capital firm focused on technologies that extend the boundaries of human performance. They invest in companies at the intersection of digital technology and neuroscience. They are interested in companies that leverage cutting-edge brain science to inform powerful technology platforms that are impacting the human experience, such as virtual and augmented reality, immersive video gaming, artificial intelligence, and closed-loop human-computer systems. Their portfolio companies are unlocking human potential in important markets: health, mind-body wellness, peak mental and physical performance, accelerated learning and training, sports, and entertainment. The partners are proven investors, entrepreneurs, neuroscientists, and technologists. They have deep domain experience and unparalleled access to innovative companies, talent, and strategic resources. Their multidisciplinary backgrounds allow us to meaningfully support exceptional entrepreneurs and executives in building category-defining companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2021 | Magnus Medical | Series A | 0 |
6/2020 | The Meta | Series A | 3.2M |
11/2015 | Eyefluence | Series B | 14M |
5/2019 | Arrive Health (formerly RxRevu) | Series A | 0 |
1/2022 | Augment AI Corp | Seed Round | 3.5M |
11/2021 | AppliedVR | Series B | 0 |
1/2021 | NextStep | Seed Round | 2.5M |
12/2018 | AIR (AI Redefined) | Seed Round | 3.5M |
6/2018 | Wisdo Health | Convertible Note | 4.1M |
9/2018 | Pymetrics | Series B | 40M |
8/2019 | NextStep | Seed Round | 3M |
2/2016 | Halo Neuroscience | Series A | 9M |
10/2019 | Cadence Neuroscience | Series A | 15M |
9/2022 | Cabservices24x7 | Series A | 30M |
1/2021 | Arrive Health (formerly RxRevu) | Series B | 7M |
10/2018 | NextStep | Seed Round | 3.1M |
2/2021 | Outside | Series B | 0 |
1/2016 | Level Ex | Seed Round | 2.1M |
1/2019 | Pear Therapeutics | Series C | 64M |
1/2020 | Mahana Therapeutics | Seed Round | 12M |
7/2021 | Ten Spot | Series A | 5M |
6/2020 | Zeitworks | Seed Round | 4.5M |
12/2021 | Sounding Board | Series B | 0 |
6/2022 | Oma Fertility | Venture Round | 0 |
8/2021 | Swing Therapeutics | Seed Round | 9M |
6/2022 | Swing Therapeutics | Series A | 0 |
10/2017 | Level Ex | Series A | 11M |
9/2021 | HumanCo | Venture Round | 0 |
12/2020 | Pear Therapeutics | Series D | 0 |
7/2021 | Woebot Health | Series B | 90M |
4/2020 | NextStep | Venture Round | 3.6M |
12/2021 | Pear Therapeutics | Post-IPO Equity | 0 |
5/2021 | Colossal Biosciences | Seed Round | 15M |
12/2018 | Freeletics | Series A | 0 |
3/2022 | Colossal Biosciences | Series A | 0 |
9/2020 | Freeletics | Series B | 0 |
8/2018 | Freeletics | Venture Round | - |
9/2017 | Pymetrics | Series A | 8M |
2/2022 | HERmd | Series A | 0 |
1/2016 | Akili Interactive Labs | Series B | 0 |
1/2017 | Two Bit Circus | Series B | 15M |
8/2021 | Mahana Therapeutics | Series B | 0 |
8/2021 | AllStripes | Series B | 50M |
10/2020 | Robust | Series A | 15M |
5/2022 | KLOWEN Braces | Series A | 0 |
6/2020 | Outside | Series A | 0 |
1/2018 | Halo Neuroscience | Series B | 13M |
3/2019 | Wade &a; Wendy | Series A | 0 |
12/2021 | Yumi | Series B | 67M |
5/2021 | ŌURA | Series C | 0 |
4/2020 | NextStep | Seed Round | 3.6M |
1/2018 | Pear Therapeutics | Series B | 50M |
10/2018 | Perceptive Automata | Series A | 16M |
5/2017 | Aira Tech Corp. | Series B | 12M |
2/2016 | Pear Therapeutics | Series A | 20M |
1/2023 | Colossal Biosciences | Series B | 150M |
3/2018 | Woebot Health | Series A | 22.8M |
4/2023 | Robust.AI | Series A | 0 |
6/2022 | JobGet | Series B | 40M |
7/2021 | Thrive | Series C | 80M |
6/2022 | Foresight Mental Health | Series C | - |
12/2022 | Enveda Biosciences | Series B | 0 |
4/2020 | Mahana Therapeutics | Series A | 8.6M |
6/2018 | Embodied | Series A | 22M |
5/2018 | Thrive | Series B | 22.8M |
3/2021 | Blue Note Therapeutics | Series A | 26.3M |
9/2021 | Blue Note Therapeutics | Series A | 5.2M |
12/2020 | Genesis Therapeutics | Series A | 52M |
8/2019 | NextStep | Series A | 0 |
3/2021 | AppliedVR | Series A | 0 |
1/2021 | NextStep | Venture Round | 0 |
10/2021 | NextStep | Series A | 0 |
7/2021 | Zeitworks | Venture Round | 2M |
9/2017 | Augment CXM | Seed Round | 5M |
5/2018 | Akili Interactive Labs | Series C | 0 |
5/2021 | Akili Interactive Labs | Series D | 0 |
6/2022 | JobGet | Series B | 0 |
6/2022 | Oma Fertility | Venture Round | 0 |
6/2022 | Swing Therapeutics | Series A | 0 |
5/2022 | KLOWEN Braces | Series A | 0 |
3/2022 | Colossal Biosciences | Series A | 0 |
2/2022 | HERmd | Series A | 0 |
1/2022 | Augment AI Corp | Seed Round | 0 |
12/2021 | Yumi | Series B | 0 |
12/2021 | Pear Therapeutics | Post-IPO Equity | 0 |
12/2021 | Sounding Board | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|